Skip to main content
Clinical Trials/NCT01344278
NCT01344278
Completed
Not Applicable

Comparative Effectiveness of Diabetes Prevention Strategies in Women With GDM

Kaiser Permanente1 site in 1 country2,480 target enrollmentApril 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
Kaiser Permanente
Enrollment
2480
Locations
1
Primary Endpoint
Primary outcome: meeting the postpartum weight goal
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The main goal of this study is to examine the comparative effectiveness of diabetes prevention strategies in women with Gestational Diabetes Mellitus (GDM) on the control of the following conditions: obesity, hyperglycemia, hypertension and depression. This randomized lifestyle intervention study will be conducted at Kaiser Permanente Northern California. Women in the intervention will receive a letter on gestational weight gain during pregnancy and in the postpartum period, a curriculum of individualized lifestyle counseling via telephone, augmented with e-mail and an interactive Web site. Patients randomized to the usual care arm will receive the standard-care telephone calls from the Perinatal Center during pregnancy and the Center's printed educational materials postpartum. Outcomes will be assessed through the electronic medical record and patient surveys conducted during pregnancy and at 6-weeks, 6- months and 1-year postpartum.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
September 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All women, 18 years of age or older, receiving medical care at Kaiser Permanente Northern California with a pregnancy complicated by gestational diabetes between March 2011 and May 2012 that have a telephone or cellular phone will be eligible.

Exclusion Criteria

  • Women with overt diabetes not recognized prior to pregnancy (any women with fasting plasma glucose \> 126 mg/dl, or any plasma glucose level over 200 mg/dl on more than 1 occasion during pregnancy) will be excluded from the analyses but will be eligible for the lifestyle intervention.

Outcomes

Primary Outcomes

Primary outcome: meeting the postpartum weight goal

Time Frame: through 12 months postpartum

Will be the proportion of women who reach their postpartum weight goal (based on their pre-pregnancy weight) and the total amount of weight change (in kilograms). Weight goals: a) reaching pre-pregnancy weight if women had a normal pre-pregnancy weight; or b) achieving a 5% reduction from pre-pregnancy weight if overweight or obese prior to pregnancy.

Secondary Outcomes

  • percent of calories from fat(through 12 months postpartum)
  • Blood pressure(through 12 months postpartum)
  • Depression(through 12 months postpartum)
  • Glycemia(through 12 months postpartum)
  • physical activity(through 12 months postpartum)

Study Sites (1)

Loading locations...

Similar Trials